BRAF and melanoma: To investigate immune responses after conformal RT, we established two melanoma tumors, i.e., a subcutaneously engrafted B16F1 (B16) and a genetically induced BrafCAxPtenf/fxTyrCreER (BRaf/Pten) tumors.